Opendata, web and dolomites


Non-invasive smart wearable solution for continuous monitoring of physiological parameters and biomarkers for chronic patientswith cardiac and respiratory diseases from the neonate to the elderly

Total Cost €


EC-Contrib. €






Project "ONALABS" data sheet

The following table provides information about the project.


Organization address
postcode: 8012
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-03-01   to  2018-08-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ONALABS INNO-HUB SL ES (BARCELONA) coordinator 50˙000.00


 Project objective

Onalabs Healthcare was born as an ambitious project, technical and emotional focused in premature births where the patient is affected with Congenital Heart Disease (CHD). These patients need 24hour Intensive care monitoring for a period of at least 10 days where 25% of their total blood is extracted to measure 4 biomarkers (Lactate, pH, CO2 and Glucose). This generates pain and a high risk of vain damage as well as potential death due to infections. Moreover, Heart and lung system problems are the first and fourth cause of death, respectively in Occidental territories, with more than 20 million deaths recorded in 2012. The solution that is offered by Onalabs with its product ‘Cardiopatch’ that addresses a potential market of 872M users. Our product does not rely on the extraction of blood to measure the 4 key parameters. We measure indirectly through a proven system of sweat analysis. This will allow us to also access the sport market and an additional 350M users in the sector of this that we target.

Targetting health care and sport, with a novel disruptive sensor we expect to drive a new market providing solutions providing high impact for society whilst growing to generate profits of 3.4M euros and employ 40 people by 2022.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ONALABS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ONALABS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)


CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More